Stock A213420 DUKSAN NEOLUX CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials DukSan Neolux Co.,Ltd

Equities

A213420

KR7213420003

Specialty Chemicals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
38,400 KRW +0.52% Intraday chart for DukSan Neolux Co.,Ltd +6.22% -13.71%
04-05 Nomura Adjusts DukSan Neolux’s Price Target to KRW56,000 From KRW54,000, Keeps at Buy MT
2023 Tranche Update on DukSan Neolux Co.,Ltd's Equity Buyback Plan announced on March 2, 2022. CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 631,463 836,749 1,351,764 963,798 1,093,050 982,517 - -
Enterprise Value (EV) 2 593.6 787.2 1,236 850.1 1,093 818.1 770.1 982.5
P/E ratio 33 x 25.1 x 28.9 x 24.8 x 30.6 x 21.8 x 17.6 x 20.1 x
Yield - - - - - - 0.04% -
Capitalization / Revenue 6.45 x 5.8 x 7.06 x 5.46 x 6.68 x 4.72 x 4.11 x 3.9 x
EV / Revenue 6.06 x 5.46 x 6.46 x 4.81 x 6.68 x 3.93 x 3.22 x 3.9 x
EV / EBITDA 24 x 17.5 x 21.6 x 16.1 x 26 x 12 x 10.1 x 13.3 x
EV / FCF 63.5 x 40.6 x 37 x 24.7 x - 22 x 16.3 x 18.7 x
FCF Yield 1.57% 2.46% 2.71% 4.05% - 4.54% 6.15% 5.35%
Price to Book 3.95 x 4.34 x 4.72 x 3.02 x - 2.48 x 2.15 x 2.04 x
Nbr of stocks (in thousands) 24,010 24,010 24,010 24,650 24,563 24,563 - -
Reference price 3 26,300 34,850 56,300 39,100 44,500 40,000 40,000 40,000
Announcement Date 20-02-19 21-02-03 22-02-22 23-03-13 24-03-18 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 97.87 144.2 191.4 176.7 163.7 208.2 239.1 251.8
EBITDA 1 24.78 45.1 57.36 52.84 42.11 68.08 76.1 74.1
EBIT 1 20.76 40.11 50.39 44.93 32.84 52.72 64.08 60.4
Operating Margin 21.21% 27.82% 26.33% 25.43% 20.06% 25.33% 26.8% 23.99%
Earnings before Tax (EBT) 1 20.78 37.76 55.83 44.79 41.75 56.52 68.97 65
Net income 1 19.16 33.34 48.4 38.92 35.82 45.41 54.91 49.42
Net margin 19.57% 23.13% 25.29% 22.03% 21.88% 21.81% 22.96% 19.63%
EPS 2 796.0 1,388 1,946 1,574 1,456 1,834 2,276 1,990
Free Cash Flow 3 9,342 19,381 33,455 34,455 - 37,180 47,360 52,550
FCF margin 9,545.32% 13,444.11% 17,483.1% 19,501.53% - 17,859.97% 19,806.93% 20,869.74%
FCF Conversion (EBITDA) 37,704.69% 42,973.7% 58,326.93% 65,202.41% - 54,612.22% 62,237.63% 70,917.68%
FCF Conversion (Net income) 48,766.98% 58,126.08% 69,129.02% 88,524.51% - 81,878.82% 86,253.78% 106,333.47%
Dividend per Share 2 - - - - - - 15.00 -
Announcement Date 20-02-19 21-02-03 22-02-22 23-03-13 24-03-18 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 58.64 46.75 41.64 39.31 47.07 48.66 28.45 42.74 71.19 47.04 45.47 51.35 52.3 54 50.85
EBITDA 1 17.9 14.62 13.99 13.24 13.55 12.04 2.111 - - 14.93 13.92 12.7 9.75 14.35 15.89
EBIT 1 16.25 12.4 12.37 10.9 11.56 10.09 0.0915 8.987 - 12.24 11.53 11.41 12 14.95 13.64
Operating Margin 27.72% 26.51% 29.71% 27.72% 24.56% 20.73% 0.32% 21.03% - 26.02% 25.35% 22.23% 22.95% 27.69% 26.83%
Earnings before Tax (EBT) 1 18.54 13.05 13.71 12.28 15.62 3.181 4.701 13.18 - 13.99 9.882 9.767 12.33 16.7 14.3
Net income 1 16.09 11.29 11.4 9.911 11.77 5.844 4.114 11.69 - 10.67 9.333 9.313 9.596 13.04 11.61
Net margin 27.44% 24.15% 27.37% 25.21% 25% 12.01% 14.46% 27.36% - 22.69% 20.53% 18.14% 18.35% 24.16% 22.83%
EPS 2 670.0 400.0 474.0 400.0 477.0 237.0 167.0 - 642.0 - 380.0 352.8 251.6 400.0 449.5
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 21-11-08 22-02-22 22-05-12 22-08-12 22-11-10 23-03-13 23-05-11 23-08-11 23-08-11 23-11-13 24-03-18 - - - -
1KRW in Billions2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 37.9 49.6 115 114 - 164 212 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 2 9,342 19,381 33,455 34,455 - 37,180 47,360 52,550
ROE (net income / shareholders' equity) 12.7% 18.9% 19.5% 12.8% - 12.2% 13.6% 10.7%
ROA (Net income/ Total Assets) 11.2% 16.6% 16.8% 11.1% - 10.7% 12% 9%
Assets 1 170.8 201.1 288.1 349.1 - 424.4 457.6 549.1
Book Value Per Share 3 6,663 8,030 11,924 12,954 - 16,137 18,562 19,645
Cash Flow per Share 3 923.0 1,769 1,846 1,980 - 2,324 2,606 -
Capex 1 12.8 23.1 11 14.5 - 22 15.6 17.9
Capex / Sales 13.09% 16.03% 5.76% 8.2% - 10.57% 6.54% 7.1%
Announcement Date 20-02-19 21-02-03 22-02-22 23-03-13 24-03-18 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for DukSan Neolux Co.,Ltd

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
DUKSAN NEOLUX CO.,LTD Stock DukSan Neolux Co.,Ltd
-13.71% 682M
ECOLAB INC. Stock Ecolab Inc.
+14.32% 64.32B
SIKA AG Stock Sika AG
-3.80% 45.95B
GIVAUDAN SA Stock Givaudan SA
+13.69% 39.61B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+20.84% 25.74B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+8.66% 18.75B
CELANESE CORPORATION Stock Celanese Corporation
+0.65% 17.23B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.03% 15.86B
SYMRISE AG Stock Symrise AG
+0.81% 15.03B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-13.28% 13.99B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. A213420 Stock
  4. Financials DukSan Neolux Co.,Ltd